ArticlePublic health genomics2018

Use and Impact of the 21-Gene Recurrence Score in Relation to the Clinical Risk of Developing Metastases in Early Breast Cancer Patients in the Netherlands.

Kay Schreuder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.